4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001708599-25-000080
Chief Scientific Officer sold 4,196 shares at $6.50 ($27,274)
- Chief Scientific Officer acquired 4,196 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2025-07-29 | Option exercise 10b5-1 | +4,196 | $0.06 | $252 | 4,196 | D: show line 1 in the form |
| Moreadith Randall Chief Scientific Officer | 2025-07-29 | Sale 10b5-1 | −4,196 | $6.50 | $27,274 | 0 | D: show line 2 in the form |
| Open-market sales · 4,196 sh · avg $6.50 · $27,274 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moreadith Randall Chief Scientific Officer | 2025-07-29 | Option exercise · Stock Option (right to buy) 10b5-1 | −4,196 | 484,490 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1753897670.xml…